z-logo
open-access-imgOpen Access
Purifying Selection against Pathogenic Mitochondrial DNA in Human T Cells
Author(s) -
Melissa Walker,
Caleb A. Lareau,
Leif S. Ludwig,
Amel Karaa,
Vijay G. Sankaran,
Aviv Regev,
Vamsi K. Mootha
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2001265
Subject(s) - heteroplasmy , mitochondrial dna , mitochondrial encephalomyopathy , melas syndrome , lactic acidosis , biology , genetics , mutation , lineage (genetic) , mitochondrial myopathy , microbiology and biotechnology , gene , biochemistry
Many mitochondrial diseases are caused by mutations in mitochondrial DNA (mtDNA). Patients' cells contain a mixture of mutant and nonmutant mtDNA (a phenomenon called heteroplasmy). The proportion of mutant mtDNA varies across patients and among tissues within a patient. We simultaneously assayed single-cell heteroplasmy and cell state in thousands of blood cells obtained from three unrelated patients who had A3243G-associated mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes. We observed a broad range of heteroplasmy across all cell types but also found markedly reduced heteroplasmy in T cells, a finding consistent with purifying selection within this lineage. We observed this pattern in six additional patients who had heteroplasmic A3243G without strokelike episodes. (Funded by the Marriott Foundation and others.).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom